Clinical trial
Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial…
NCT00483587 · University Medical Center Groningen, Other · Completed
Key facts
| NCT number | NCT00483587 |
|---|---|
| Title | Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction? |
| Official title | A Safety and Efficacy Study to Evaluate Intravenous Heme Arginate Infusion in Patients With an Acute Coronary Syndrome Without ST-elevation (NSTEMI) |
| Acronym | HAEM |
| Lead sponsor | University Medical Center Groningen, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Heme arginate |
| Enrollment | 15 |
| Start date | Jul 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Jun 7, 2007 |
| Last update posted | Sep 20, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: